ReviewJournal of diabetes and metabolic disorders2024
National innovation system for diabetes and metabolic disorders can promote biomedical research accountability; a literature review and designing a conceptual framework.
Review in Journal of diabetes and metabolic disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Diabetes is one of the leading causes of death and health challenges in most countries and Iran. There is a domestic need to design an innovation system for healthcare through the integration of science and related industries in the country to overcome its specific challenges and complications. The present research aims to review the existing literature and experiences in designing a national innovation system in the field of diabetes and metabolic disorders to improve the research accountability in this field based on society's real needs. Methods: Four steps were carried out as an examination of challenges and costs of diabetes, a thorough review of relevant literature and expert opinion, investigation of the status of research responsiveness to the real needs of society In Iran and the world, examination the types, components and the requirements of innovation systems and designing the National Innovation System for diabetes and metabolic disorders in Iran. Results: We identified ten components for diabetes and metabolic disorders innovation system, which were classified under four categories. Conclusions: The effective communication of 10 components, which are included in this study, is an essential element that can play a vital role in the effectiveness of diabetes and metabolic disorders innovation system in order to meet the community needs. Moreover, these components were categorized by experts in four groups of policymaking, financing, research and development, and education, as the functions of the National Innovation System for diabetes and metabolic disorders in Iran.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.